Positive analyst view drives Karyopharm Therapeutics Inc (NASDAQ: KPTI) stock higher
Karyopharm Therapeutics Inc (NASDAQ: KPTI), an oncology-focused pharmaceutical company, stock rose over 1.4% on Jan 21st, 2020 (as of 12:08 pm GMT-5; Source: Google finance)…
